Pharmacotherapy of psychiatric inpatients with mental and behavioral disorders caused by sedatives or hypnotics (F13): Results from an observational pharmacovigilance program between 2000 and 2017

Pharmacotherapy of psychiatric inpatients with mental and behavioral disorders caused by sedatives or hypnotics (F13): Results from an observational pharmacovigilance program between 2000 and 2017

Abstract Background The treatment of choice for substance use disorder (SUD) caused by sedatives, hypnotics, and anxiolytics (SHA) is to slowly taper the dose of the implicated substance to the point of abstinence, thereby minimizing withdrawal symptoms. Concomitant pharmacotherapy may be indicated...

Full description

Saved in:
Bibliographic Details
Main Authors: Philipp Pauwels, Beatrice Haack, Sermin Toto, Johanna Seifert, Renate Grohmann, Martin Heinze, Oliver Zolk, Phileas Johannes Proskynitopoulos, Michael Schneider, Timo Greiner
Format: Article
Language:English
Published: BMC 2025-06-01
Series:Addiction Science & Clinical Practice
Subjects:
Sedatives
Hypnotics
Anxiolytics
Psychotropic drugs
Tranquilizing drugs
AMSP
Online Access:https://doi.org/10.1186/s13722-025-00579-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s13722-025-00579-6

Similar Items